Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
about
Dendritic Cells and Their Multiple Roles during Malaria InfectionWhy functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmidsInterleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum.Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3Advances and challenges in malaria vaccine development.Diversifying selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum in ThailandA Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopesT-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic.Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02AEffector and memory CD8+ T cells as seen in immunity to malaria.Protective and pathogenic roles of CD8+ T cells during malaria infection.Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria.Pre-erythrocytic malaria vaccines: identifying the targets.Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.Genetically engineered, attenuated whole-cell vaccine approaches for malaria.Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicityHuman infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.Polymorphism in liver-stage malaria vaccine candidate proteins: immune evasion and implications for vaccine design.HLA-A*01-restricted cytotoxic T-lymphocyte epitope from the Plasmodium falciparum circumsporozoite protein.Toward clinical trials of DNA vaccines against malaria.The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT.Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria.Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.
P2860
Q26750593-2007E1B0-9D0A-4B22-AA84-8ED4DD907AB9Q33587443-B891801E-3AE3-48AA-97D2-B1C0D1B08E29Q33761524-5EB1521F-21A0-4E6F-85D9-D480FC99DC7FQ33876788-47B9176A-DC4D-4A8A-B142-E64F796D8D72Q34003047-4F94BB5D-3E9D-48DF-9CA8-51D3C071F171Q34145333-E5D5115F-367E-464E-ADD2-AE94802A45AAQ35109124-D57EB71A-71AD-42C5-AD68-3EC0379FA9C1Q35122498-DC0742FA-762D-4D93-9BE1-271202F83417Q35553683-AAA0AE8E-4118-4760-A3E7-60F5D33BAB36Q35560038-510986AD-DD97-4664-A005-E46CF0B62B77Q35675454-0726B9C4-CF47-481F-8109-B50BA7E5DA75Q35689159-A3A52635-0C6D-46DC-8DAD-DCA2B3351ADCQ35884254-92BE8290-C852-46E3-B115-6F2788FB83EFQ36378328-2177754D-502F-4A30-B567-2A2135CACF32Q36455241-2982F8B5-1F0E-4263-96ED-72A430D2F184Q36644236-CF293CA7-26B6-4662-9014-A818950656BDQ36674065-73EBF5E0-314F-488C-B2AC-1115758FE467Q36811011-ABEC446F-BB28-4CDB-BD81-656B78C35B0BQ37118222-FF1850E9-5A91-41B4-9122-1DED921E3F75Q37385100-BE7D575A-7A10-4F9D-BDC4-A91A0C8EBA69Q38648583-D241564F-87DE-4A4F-A225-5E9C41EBBB36Q39519692-24D8FAED-6BAE-4806-A686-58ADB38ACEBCQ41604732-2E5A761B-19B0-41B5-A197-01855FF3D55EQ44170879-10B0841B-717F-4420-9A6F-EB5C72D23A12Q45749788-94E977FD-7BDC-445B-BB40-20642866640DQ47872316-8A0C19F3-F052-4F06-BE43-FBB3BAABF9C9Q47907194-BEA1A2EB-881E-4AE9-9FA6-35D96F029131Q47925938-D12662CC-766F-493D-8500-42D0B5F10A73Q50347547-DB7637C5-467D-4D9E-AFE9-6F9103E550AD
P2860
Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Irradiated sporozoite vaccine ...... sporozoite surface protein 2.
@ast
Irradiated sporozoite vaccine ...... sporozoite surface protein 2.
@en
type
label
Irradiated sporozoite vaccine ...... sporozoite surface protein 2.
@ast
Irradiated sporozoite vaccine ...... sporozoite surface protein 2.
@en
prefLabel
Irradiated sporozoite vaccine ...... sporozoite surface protein 2.
@ast
Irradiated sporozoite vaccine ...... sporozoite surface protein 2.
@en
P2093
P2860
P921
P356
P1476
Irradiated sporozoite vaccine ...... sporozoite surface protein 2.
@en
P2093
Coligan JE
Houghten RA
P2860
P304
P356
10.1084/JEM.182.5.1435
P407
P577
1995-11-01T00:00:00Z